Protein expression of melanocyte growth factors (bFGF, SCF) and their receptors (FGFR-1, c-kit) in nevi and melanoma

被引:45
作者
Giehl, K. A. [1 ]
Naegle, U. [1 ]
Volkenandt, M. [1 ]
Berking, C. [1 ]
机构
[1] Univ Munich, Dept Dermatol, D-80337 Munich, Germany
关键词
D O I
10.1111/j.1600-0560.2006.00569.x
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background: Basic fibroblast growth factor ( bFGF) and stem cell factor (SCF) are essential growth factors for melanocytes which carry the receptors FGFR-1 for bFGF and c-kit for SCF. Because both factors may be involved in melanoma development, the expression of bFGF/FGFR-1 and SCF/c-kit was investigated in melanocytic tumors of different progression stages. Methods: Fifty primary melanomas and 44 melanocytic nevi were analyzed for the expression of SCF, c-kit, bFGF, and FGFR- 1 by immunohistochemistry. Results: In melanoma, SCF and c-kit were expressed in 76 and 84%, respectively, and coexpressed in 66%. bFGF and FGFR-1 were expressed in 45 and 86%, respectively, and coexpressed in 46%. In melanocytic nevi, SCF was expressed in 23% and c-kit in 70% while coexpression was more common in dysplastic (39%) than non-dysplastic subtypes (8%). bFGF and FGFR-1 were expressed in 55 and 67%, respectively, while coexpression was found in 47% but varied considerably between different histological subtypes. Conclusions: SCF and c-kit were frequently expressed by melanomas and dysplastic nevi suggesting an autocrine growth mechanism as described for bFGF. In both nevi and melanoma, c-kit was almost exclusively found in the epidermis while bFGF was more common in the dermis. Thus the growth factor/receptor expression seems to depend on the cutaneous localization of the melanocytic tumors.
引用
收藏
页码:7 / 14
页数:8
相关论文
共 37 条
  • [1] Expression of fibroblast growth factor receptors in naevus-cell naevus and malignant melanoma
    Ahmed, NU
    Ueda, M
    Ito, A
    Ohashi, A
    Funasaka, Y
    Ichihashi, M
    [J]. MELANOMA RESEARCH, 1997, 7 (04) : 299 - 305
  • [2] The prognostic significance of basic fibroblast growth factor in cutaneous malignant melanoma
    AlAlousi, S
    Barnhill, R
    Blessing, K
    Barksdale, S
    [J]. JOURNAL OF CUTANEOUS PATHOLOGY, 1996, 23 (06) : 506 - 510
  • [3] Expression of basic fibroblast growth factor in desmoplastic melanoma
    AlAlousi, S
    Carlson, JA
    Blessing, K
    Cook, M
    Karaoli, T
    Barnhill, RL
    [J]. JOURNAL OF CUTANEOUS PATHOLOGY, 1996, 23 (02) : 118 - 125
  • [4] FGF expression allows nevus cells to survive in three-dimensional collagen gel under conditions that induce apoptosis in normal human melanocytes
    Alanko, T
    Rosenberg, M
    Saksela, O
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1999, 113 (01) : 111 - 116
  • [5] ALBINO AP, 1991, CANCER RES, V51, P4815
  • [6] An immunohistochemical evaluation of c-kit (CD-117) expression in malignant melanoma, and results of imatinib mesylate (Gleevec) therapy in three patients
    Alexis, JB
    Martinez, AE
    Lutzky, J
    [J]. MELANOMA RESEARCH, 2005, 15 (04) : 283 - 285
  • [7] PROLIFERATION OF HUMAN-MALIGNANT MELANOMAS IS INHIBITED BY ANTISENSE OLIGODEOXYNUCLEOTIDES TARGETED AGAINST BASIC FIBROBLAST GROWTH-FACTOR
    BECKER, D
    MEIER, CB
    HERLYN, M
    [J]. EMBO JOURNAL, 1989, 8 (12) : 3685 - 3691
  • [8] Induction of melanoma phenotypes in human skin by growth factors and ultraviolet B
    Berking, C
    Takemoto, R
    Satyamoorthy, K
    Shirakawa, T
    Eskandarpour, M
    Hansson, J
    VanBelle, PA
    Elder, DE
    Herlyn, M
    [J]. CANCER RESEARCH, 2004, 64 (03) : 807 - 811
  • [9] Biological roles of fibroblast growth factor-2
    Bikfalvi, A
    Klein, S
    Pintucci, G
    Rifkin, DB
    [J]. ENDOCRINE REVIEWS, 1997, 18 (01) : 26 - 45
  • [10] Expression of basic fibroblast growth factor and vascular endothelial growth factor in primary and metastatic melanoma from the same patients
    Birck, A
    Kirkin, AF
    Zeuthen, J
    Hou-Jensen, K
    [J]. MELANOMA RESEARCH, 1999, 9 (04) : 375 - 381